Enzalutamide monotherapy: Extended follow-up of a phase II study in hormone-naive prostate cancer patients.

Bertrand Tombal, Michael Borre, Per Rathenborg, Patrick Werbrouck, Hendrik Van Poppel, Axel Heidenreich, Peter Iversen, Johan Braeckman, Jiri Heracek, Edwina Baskin-Bey, Taoufik Ouatas, Frank Perabo, De Phung, Matthew R. Smith

Original languageEnglish
JournalJournal of Clinical Oncology
Issue number4_suppl
Pages (from-to)62
Number of pages1
Publication statusPublished - 2014

Cite this